HEADER IMMUNE SYSTEM 02-AUG-16 5L2J TITLE CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH C36-GMM COMPND MOL_ID: 1; COMPND 2 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD1B; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD1B; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HI5; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASBACDUAL; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 16 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: HI5; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PFASBACDUAL KEYWDS CD1B, LIPID, TB, MTB, GMM, TUBERCULOSIS, GEM T CELL, TCR, T CELL, KEYWDS 2 IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.GRAS,A.SHAHINE,J.LE NOURS,J.ROSSJOHN REVDAT 4 04-OCT-23 5L2J 1 HETSYN LINK REVDAT 3 29-JUL-20 5L2J 1 COMPND REMARK HETNAM HETSYN REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 07-DEC-16 5L2J 1 REMARK REVDAT 1 16-NOV-16 5L2J 0 JRNL AUTH S.GRAS,I.VAN RHIJN,A.SHAHINE,T.Y.CHENG,M.BHATI,L.L.TAN, JRNL AUTH 2 H.HALIM,K.D.TUTTLE,L.GAPIN,J.LE NOURS,D.B.MOODY,J.ROSSJOHN JRNL TITL T CELL RECEPTOR RECOGNITION OF CD1B PRESENTING A JRNL TITL 2 MYCOBACTERIAL GLYCOLIPID. JRNL REF NAT COMMUN V. 7 13257 2016 JRNL REFN ESSN 2041-1723 JRNL PMID 27807341 JRNL DOI 10.1038/NCOMMS13257 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 50306 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 2529 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.94 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3668 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2176 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3494 REMARK 3 BIN R VALUE (WORKING SET) : 0.2164 REMARK 3 BIN FREE R VALUE : 0.2426 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.74 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 174 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2996 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 180 REMARK 3 SOLVENT ATOMS : 366 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.24440 REMARK 3 B22 (A**2) : -1.11310 REMARK 3 B33 (A**2) : -0.13140 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.171 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.095 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.090 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.090 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.088 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3356 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4568 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1208 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 80 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 486 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3356 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 432 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3951 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.78 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5L2J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1000223118. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.12 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 41.360 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.20 REMARK 200 R MERGE FOR SHELL (I) : 2.36200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2H26 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-30 PEG 4000, 0.2M NAI, 2% EG, PH 8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.83000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.66500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.05500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.66500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.83000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.05500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 2 REMARK 465 ALA A 3 REMARK 465 ASP A 284 REMARK 465 ILE A 285 REMARK 465 PHE A 286 REMARK 465 GLU A 287 REMARK 465 ALA A 288 REMARK 465 GLN A 289 REMARK 465 LYS A 290 REMARK 465 ILE A 291 REMARK 465 GLU A 292 REMARK 465 TRP A 293 REMARK 465 HIS A 294 REMARK 465 GLU A 295 REMARK 465 HIS A 296 REMARK 465 HIS A 297 REMARK 465 HIS A 298 REMARK 465 HIS A 299 REMARK 465 HIS A 300 REMARK 465 HIS A 301 REMARK 465 ASP B 100 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -119.81 52.08 REMARK 500 PHE A 123 -51.20 -128.83 REMARK 500 LEU A 282 35.51 -91.97 REMARK 500 LYS B 50 35.79 -84.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 6UL A 401 REMARK 610 ACT A 410 REMARK 610 ACT A 411 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5L2K RELATED DB: PDB DBREF 5L2J A 2 278 UNP P29016 CD1B_HUMAN 20 296 DBREF 5L2J B 3 100 UNP P61769 B2MG_HUMAN 21 118 SEQADV 5L2J GLY A 279 UNP P29016 EXPRESSION TAG SEQADV 5L2J SER A 280 UNP P29016 EXPRESSION TAG SEQADV 5L2J GLY A 281 UNP P29016 EXPRESSION TAG SEQADV 5L2J LEU A 282 UNP P29016 EXPRESSION TAG SEQADV 5L2J ASN A 283 UNP P29016 EXPRESSION TAG SEQADV 5L2J ASP A 284 UNP P29016 EXPRESSION TAG SEQADV 5L2J ILE A 285 UNP P29016 EXPRESSION TAG SEQADV 5L2J PHE A 286 UNP P29016 EXPRESSION TAG SEQADV 5L2J GLU A 287 UNP P29016 EXPRESSION TAG SEQADV 5L2J ALA A 288 UNP P29016 EXPRESSION TAG SEQADV 5L2J GLN A 289 UNP P29016 EXPRESSION TAG SEQADV 5L2J LYS A 290 UNP P29016 EXPRESSION TAG SEQADV 5L2J ILE A 291 UNP P29016 EXPRESSION TAG SEQADV 5L2J GLU A 292 UNP P29016 EXPRESSION TAG SEQADV 5L2J TRP A 293 UNP P29016 EXPRESSION TAG SEQADV 5L2J HIS A 294 UNP P29016 EXPRESSION TAG SEQADV 5L2J GLU A 295 UNP P29016 EXPRESSION TAG SEQADV 5L2J HIS A 296 UNP P29016 EXPRESSION TAG SEQADV 5L2J HIS A 297 UNP P29016 EXPRESSION TAG SEQADV 5L2J HIS A 298 UNP P29016 EXPRESSION TAG SEQADV 5L2J HIS A 299 UNP P29016 EXPRESSION TAG SEQADV 5L2J HIS A 300 UNP P29016 EXPRESSION TAG SEQADV 5L2J HIS A 301 UNP P29016 EXPRESSION TAG SEQRES 1 A 300 HIS ALA PHE GLN GLY PRO THR SER PHE HIS VAL ILE GLN SEQRES 2 A 300 THR SER SER PHE THR ASN SER THR TRP ALA GLN THR GLN SEQRES 3 A 300 GLY SER GLY TRP LEU ASP ASP LEU GLN ILE HIS GLY TRP SEQRES 4 A 300 ASP SER ASP SER GLY THR ALA ILE PHE LEU LYS PRO TRP SEQRES 5 A 300 SER LYS GLY ASN PHE SER ASP LYS GLU VAL ALA GLU LEU SEQRES 6 A 300 GLU GLU ILE PHE ARG VAL TYR ILE PHE GLY PHE ALA ARG SEQRES 7 A 300 GLU VAL GLN ASP PHE ALA GLY ASP PHE GLN MET LYS TYR SEQRES 8 A 300 PRO PHE GLU ILE GLN GLY ILE ALA GLY CYS GLU LEU HIS SEQRES 9 A 300 SER GLY GLY ALA ILE VAL SER PHE LEU ARG GLY ALA LEU SEQRES 10 A 300 GLY GLY LEU ASP PHE LEU SER VAL LYS ASN ALA SER CYS SEQRES 11 A 300 VAL PRO SER PRO GLU GLY GLY SER ARG ALA GLN LYS PHE SEQRES 12 A 300 CYS ALA LEU ILE ILE GLN TYR GLN GLY ILE MET GLU THR SEQRES 13 A 300 VAL ARG ILE LEU LEU TYR GLU THR CYS PRO ARG TYR LEU SEQRES 14 A 300 LEU GLY VAL LEU ASN ALA GLY LYS ALA ASP LEU GLN ARG SEQRES 15 A 300 GLN VAL LYS PRO GLU ALA TRP LEU SER SER GLY PRO SER SEQRES 16 A 300 PRO GLY PRO GLY ARG LEU GLN LEU VAL CYS HIS VAL SER SEQRES 17 A 300 GLY PHE TYR PRO LYS PRO VAL TRP VAL MET TRP MET ARG SEQRES 18 A 300 GLY GLU GLN GLU GLN GLN GLY THR GLN LEU GLY ASP ILE SEQRES 19 A 300 LEU PRO ASN ALA ASN TRP THR TRP TYR LEU ARG ALA THR SEQRES 20 A 300 LEU ASP VAL ALA ASP GLY GLU ALA ALA GLY LEU SER CYS SEQRES 21 A 300 ARG VAL LYS HIS SER SER LEU GLU GLY GLN ASP ILE ILE SEQRES 22 A 300 LEU TYR TRP ARG GLY SER GLY LEU ASN ASP ILE PHE GLU SEQRES 23 A 300 ALA GLN LYS ILE GLU TRP HIS GLU HIS HIS HIS HIS HIS SEQRES 24 A 300 HIS SEQRES 1 B 98 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 98 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 98 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 98 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 98 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 98 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 98 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 98 ILE VAL LYS TRP ASP ARG ASP HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET FUC C 6 10 HET FUC C 7 10 HET 6UL A 401 26 HET NAG A 402 14 HET ACT A 410 3 HET ACT A 411 3 HET CL A 412 1 HET CL A 413 1 HET 70E A 414 50 HET NA B 201 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM 6UL TETRACOSYL PALMITATE HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETNAM 70E 6-O-[(2R,3R)-3-HYDROXY-2-TETRADECYLDOCOSANOYL]-ALPHA-L- HETNAM 2 70E IDOPYRANOSE HETNAM NA SODIUM ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN 70E C36 GLUCOSE MONOMYCOLATE; C36 GMM FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 3 MAN 2(C6 H12 O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 4 6UL C40 H80 O2 FORMUL 6 ACT 2(C2 H3 O2 1-) FORMUL 8 CL 2(CL 1-) FORMUL 10 70E C42 H82 O8 FORMUL 11 NA NA 1+ FORMUL 12 HOH *366(H2 O) HELIX 1 AA1 SER A 59 PHE A 88 1 30 HELIX 2 AA2 GLY A 137 ILE A 149 1 13 HELIX 3 AA3 GLY A 153 GLU A 164 1 12 HELIX 4 AA4 GLU A 164 GLY A 177 1 14 HELIX 5 AA5 GLY A 177 GLN A 182 1 6 HELIX 6 AA6 HIS A 265 GLU A 269 5 5 SHEET 1 AA1 8 THR A 46 PHE A 49 0 SHEET 2 AA1 8 LEU A 35 ASP A 41 -1 N ASP A 41 O THR A 46 SHEET 3 AA1 8 TRP A 23 LEU A 32 -1 N LEU A 32 O LEU A 35 SHEET 4 AA1 8 SER A 9 ASN A 20 -1 N SER A 17 O GLN A 25 SHEET 5 AA1 8 PHE A 94 LEU A 104 -1 O PHE A 94 N PHE A 18 SHEET 6 AA1 8 ILE A 110 LEU A 118 -1 O ALA A 117 N GLN A 97 SHEET 7 AA1 8 LEU A 121 LYS A 127 -1 O PHE A 123 N GLY A 116 SHEET 8 AA1 8 SER A 130 PRO A 133 -1 O VAL A 132 N SER A 125 SHEET 1 AA2 4 GLU A 188 PRO A 195 0 SHEET 2 AA2 4 ARG A 201 PHE A 211 -1 O HIS A 207 N TRP A 190 SHEET 3 AA2 4 TRP A 243 ALA A 252 -1 O VAL A 251 N LEU A 202 SHEET 4 AA2 4 GLN A 231 LEU A 232 -1 N GLN A 231 O THR A 248 SHEET 1 AA3 4 GLU A 188 PRO A 195 0 SHEET 2 AA3 4 ARG A 201 PHE A 211 -1 O HIS A 207 N TRP A 190 SHEET 3 AA3 4 TRP A 243 ALA A 252 -1 O VAL A 251 N LEU A 202 SHEET 4 AA3 4 LEU A 236 PRO A 237 -1 N LEU A 236 O TYR A 244 SHEET 1 AA4 4 GLN A 225 GLU A 226 0 SHEET 2 AA4 4 TRP A 217 ARG A 222 -1 N ARG A 222 O GLN A 225 SHEET 3 AA4 4 LEU A 259 LYS A 264 -1 O SER A 260 N MET A 221 SHEET 4 AA4 4 ILE A 273 TYR A 276 -1 O LEU A 275 N CYS A 261 SHEET 1 AA5 4 LYS B 8 SER B 13 0 SHEET 2 AA5 4 ASN B 23 PHE B 32 -1 O SER B 30 N LYS B 8 SHEET 3 AA5 4 PHE B 64 PHE B 72 -1 O THR B 70 N LEU B 25 SHEET 4 AA5 4 GLU B 52 HIS B 53 -1 N GLU B 52 O TYR B 69 SHEET 1 AA6 4 LYS B 8 SER B 13 0 SHEET 2 AA6 4 ASN B 23 PHE B 32 -1 O SER B 30 N LYS B 8 SHEET 3 AA6 4 PHE B 64 PHE B 72 -1 O THR B 70 N LEU B 25 SHEET 4 AA6 4 SER B 57 PHE B 58 -1 N SER B 57 O TYR B 65 SHEET 1 AA7 4 GLU B 46 ARG B 47 0 SHEET 2 AA7 4 GLU B 38 LYS B 43 -1 N LYS B 43 O GLU B 46 SHEET 3 AA7 4 TYR B 80 ASN B 85 -1 O ALA B 81 N LEU B 42 SHEET 4 AA7 4 LYS B 93 LYS B 96 -1 O VAL B 95 N CYS B 82 SSBOND 1 CYS A 102 CYS A 166 1555 1555 2.12 SSBOND 2 CYS A 131 CYS A 145 1555 1555 2.06 SSBOND 3 CYS A 206 CYS A 261 1555 1555 2.02 SSBOND 4 CYS B 27 CYS B 82 1555 1555 2.02 LINK ND2 ASN A 20 C1 NAG A 402 1555 1555 1.43 LINK ND2 ASN A 57 C1 NAG C 1 1555 1555 1.43 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.40 LINK O3 NAG C 1 C1 FUC C 6 1555 1555 1.43 LINK O6 NAG C 1 C1 FUC C 7 1555 1555 1.39 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.40 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.42 LINK O6 BMA C 3 C1 MAN C 5 1555 1555 1.40 CISPEP 1 TYR A 92 PRO A 93 0 -1.43 CISPEP 2 TYR A 212 PRO A 213 0 1.78 CISPEP 3 HIS B 33 PRO B 34 0 -2.20 CRYST1 57.660 78.110 91.330 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017343 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012802 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010949 0.00000